| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $19.1M | +45.4% |
| SG&A Expense | $7.6M | -6.5% |
| Operating Income | -$26.7M | -25.5% |
| Pre-tax Income | -$24.4M | -26.2% |
| Income Tax | $30K | -30.2% |
| Net Income | -$24.4M | -26.1% |
| EPS (Basic) | -$0.60 | +0.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.0M | -33.4% |
| Short-term Investments | $41.1M | -15.0% |
| Accounts Receivable | $236K | -36.0% |
| Current Assets | $44.6M | -16.9% |
| Total Assets | $46.3M | -14.4% |
| Current Liabilities | $5.4M | +93.5% |
| Stockholders' Equity | $40.7M | -20.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$22.1M | -17.9% |
| Capital Expenditures | $25K | +4.2% |
| Investing Cash Flow | $8.6M | +146.8% |
| Financing Cash Flow | $12.0M | -67.4% |
| Free Cash Flow | -$22.1M | -17.9% |